Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Allergan claims prostaglandin derivatives with vasodilating activity

April 25, 1997

Senju describes new calpain inhibitor

April 10, 1997

IDE sought for new technique for glaucoma surgery

April 2, 1997

Selective CB2 receptor agonists prepared by Merck Frosst

April 2, 1997

Ciba Vision launches Ophthalin in U.K.

April 1, 1997

Two dose regimens of latanoprost compared in glaucoma patients

March 25, 1997

Alphagan receives first European approval

March 25, 1997

Alcon prepares carbonic anhydrase inhibitors

March 13, 1997

Positive phase I results for new formulation of lexipafant

March 12, 1997

Gene linked to juvenile macular degeneration cloned

March 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...